Boston Scientific (BSX) Tops Q3 EPS by 4c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Boston Scientific (BSX) PT Raised to $98 at RBC Capital
October 24, 2024 6:37 AM EDTRBC Capital analyst Shagun Singh raised the price target on Boston Scientific (NYSE: BSX) to $98.00 (from $95.00) while maintaining a Outperform rating.
The analyst comments "BSX reported impressive Q3'24 results (+18% y/y organic or 1,120bps above end-markets, and 26% y/y EPS growth)... More
CL King Reiterates Buy Rating on Boston Scientific (BSX)
October 24, 2024 6:34 AM EDTCL King analyst Kristen Stewart reiterated a Buy rating and $90.00 price target on Boston Scientific (NYSE: BSX)
The analyst comments "Boston Scientific (BSX) reported 3Q24 results that came in well above consensus expectations. We expect the stock to react favorably to the... More
